Literature DB >> 12467942

Nocturnal cortisol and melatonin secretion in primary insomnia.

Dieter Riemann1, Torsten Klein, Andrea Rodenbeck, Bernd Feige, Andrea Horny, Ruth Hummel, Gesa Weske, Anam Al-Shajlawi, Ulrich Voderholzer.   

Abstract

The present study investigated evening and nocturnal serum cortisol and melatonin concentrations in patients with primary insomnia to test if this clinical condition is accompanied by an increase of cortisol secretion and a simultaneous decrease of nocturnal melatonin production. Ten drug-free patients (4 males, 6 females) with primary insomnia (mean age+/-S.D.: 39.2+/-9.1 years) and 10 age- and gender-matched healthy controls participated in the study. All subjects spent three consecutive nights in the sleep laboratory with polysomnography. Measurement of cortisol and melatonin (from 19:00 h to 09:00 h) was performed prior to and during the last laboratory night. Contrary to expectation, cortisol secretion did not differ between healthy controls and insomniac patients. On the other hand, nocturnal melatonin production was significantly diminished in insomniac patients. Polysomnographically determined sleep patterns, in contrast to subjective ratings of sleep, demonstrated only minor alterations of sleep in the insomniac group. The lack of increased cortisol secretion in the patients with primary insomnia indicates that results from studies on the biological consequences of experimental sleep loss in healthy subjects cannot be applied to primary insomnia in general, especially if there are only minor objective sleep alterations. In spite of the negligible objective sleep disturbances in the present sample, nocturnal melatonin production was reduced, which tentatively suggests a role for this hormone in primary insomniacs. The pathophysiological significance of this finding is, however, still a matter of debate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467942     DOI: 10.1016/s0165-1781(02)00249-4

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  29 in total

Review 1.  The therapeutic potential of melatonin: a review of the science.

Authors:  Samir Malhotra; Girish Sawhney; Promila Pandhi
Journal:  MedGenMed       Date:  2004-04-13

Review 2.  Insomnia: definition, prevalence, etiology, and consequences.

Authors:  Thomas Roth
Journal:  J Clin Sleep Med       Date:  2007-08-15       Impact factor: 4.062

3.  Insomnia with Short Sleep Duration: Nosological, Diagnostic, and Treatment Implications.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza
Journal:  Sleep Med Clin       Date:  2013-09-01

Review 4.  Insomnia and its impact on physical and mental health.

Authors:  Julio Fernandez-Mendoza; Alexandros N Vgontzas
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

5.  Association of Sleep Duration and Quality With Alterations in the Hypothalamic-Pituitary Adrenocortical Axis: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Cecilia Castro-Diehl; Ana V Diez Roux; Susan Redline; Teresa Seeman; Sandi E Shrager; Steven Shea
Journal:  J Clin Endocrinol Metab       Date:  2015-06-05       Impact factor: 5.958

Review 6.  The pathophysiology of insomnia.

Authors:  Jessica C Levenson; Daniel B Kay; Daniel J Buysse
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

7.  Familial Risk for Insomnia Is Associated With Abnormal Cortisol Response to Stress.

Authors:  Christopher L Drake; Philip Cheng; David M Almeida; Thomas Roth
Journal:  Sleep       Date:  2017-10-01       Impact factor: 5.849

Review 8.  Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza; Duanping Liao; Edward O Bixler
Journal:  Sleep Med Rev       Date:  2013-02-16       Impact factor: 11.609

Review 9.  Sleep: important considerations for the prevention of cardiovascular disease.

Authors:  Michael A Grandner; Pamela Alfonso-Miller; Julio Fernandez-Mendoza; Safal Shetty; Sundeep Shenoy; Daniel Combs
Journal:  Curr Opin Cardiol       Date:  2016-09       Impact factor: 2.161

Review 10.  [Insomnias: I. Aetiology, pathophysiology and diagnostics].

Authors:  D Riemann; G Hajak
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.